151 related articles for article (PubMed ID: 22980617)
1. Temozolomide for relapsed primary CNS lymphoma.
Osmani AH; Masood N
J Coll Physicians Surg Pak; 2012 Sep; 22(9):594-5. PubMed ID: 22980617
[TBL] [Abstract][Full Text] [Related]
2. A single centre study of the treatment of relapsed primary central nervous system lymphoma (PCNSL) with single agent temozolomide.
Wong SF; Gan HK; Cher L
J Clin Neurosci; 2012 Nov; 19(11):1501-5. PubMed ID: 22995759
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of temozolomide plus concurrent whole-brain radiation followed by TNV regimen as adjuvant therapy for patients with newly diagnosed primary CNS lymphoma.
Wang Y; Liu B; Xu D; Zhao H; Zhu Y; Xu J; Tao R
Neurol India; 2013; 61(3):260-4. PubMed ID: 23860145
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
5. Primary CNS lymphoma.
Gerstner E; Batchelor T
Expert Rev Anticancer Ther; 2007 May; 7(5):689-700. PubMed ID: 17492932
[TBL] [Abstract][Full Text] [Related]
6. Salvage therapy with temozolomide in an immunocompetent patient with primary brain lymphoma.
Reni M; Ferreri AJ; Landoni C; Villa E
J Natl Cancer Inst; 2000 Apr; 92(7):575-6. PubMed ID: 10749917
[No Abstract] [Full Text] [Related]
7. Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
Mappa S; Marturano E; Licata G; Frezzato M; Frungillo N; Ilariucci F; Stelitano C; Ferrari A; Sorarù M; Vianello F; Baldini L; Proserpio I; Foppoli M; Assanelli A; Reni M; Caligaris-Cappio F; Ferreri AJ
Hematol Oncol; 2013 Sep; 31(3):143-50. PubMed ID: 23161567
[TBL] [Abstract][Full Text] [Related]
8. Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas.
Wong ET; Tishler R; Barron L; Wu JK
Cancer; 2004 Jul; 101(1):139-45. PubMed ID: 15221999
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic Brachytherapy with Iodine-125 Seeds Plus Temozolomide Induced Complete and Durable Remission in a Patient with Recurrent Primary Central Nervous System Lymphoma.
Zheng J; Wang C; Liu F
World Neurosurg; 2018 Sep; 117():316-320. PubMed ID: 29960094
[TBL] [Abstract][Full Text] [Related]
10. Patterns of relapse after successful completion of initial therapy in primary central nervous system lymphoma: a case series.
Patel MP; Kirkpatrick JP; Johnson MO; Healy P; Herndon JE; Lipp ES; Miller ES; Desjardins A; Randazzo D; Friedman HS; Ashley DM; Peters KB
J Neurooncol; 2020 Apr; 147(2):477-483. PubMed ID: 32140975
[TBL] [Abstract][Full Text] [Related]
11. Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide.
Enting RH; Demopoulos A; DeAngelis LM; Abrey LE
Neurology; 2004 Sep; 63(5):901-3. PubMed ID: 15365145
[TBL] [Abstract][Full Text] [Related]
12. Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.
Abrey LE; Moskowitz CH; Mason WP; Crump M; Stewart D; Forsyth P; Paleologos N; Correa DD; Anderson ND; Caron D; Zelenetz A; Nimer SD; DeAngelis LM
J Clin Oncol; 2003 Nov; 21(22):4151-6. PubMed ID: 14615443
[TBL] [Abstract][Full Text] [Related]
13. Temozolomide as a Single Agent Maintenance Therapy in Elderly Patients With Primary CNS Lymphoma.
Faivre G; Butler MJ; Le I; Brenner A
Clin Lymphoma Myeloma Leuk; 2019 Oct; 19(10):665-669. PubMed ID: 31351990
[TBL] [Abstract][Full Text] [Related]
14. Atypical presentation of primary central nervous system non-Hodgkin lymphoma in immunocompetent young adults.
Cheatle JT; Aizenberg MR; Weinberg JS; Surdell DL
World Neurosurg; 2013; 79(3-4):593.e9-13. PubMed ID: 22885166
[TBL] [Abstract][Full Text] [Related]
15. Advances and challenges in the treatment of primary central nervous system lymphoma.
Yang H; Xun Y; Yang A; Liu F; You H
J Cell Physiol; 2020 Dec; 235(12):9143-9165. PubMed ID: 32420657
[TBL] [Abstract][Full Text] [Related]
16. Primary Central Nervous System Lymphoma in an Immunocompetent Young Adult Patient: A Rare Case.
Wirdah A; Djamaludin N; Syahrir M; Andayani YD; Andriani M; Diansari Y
Acta Med Indones; 2023 Jan; 55(1):107-109. PubMed ID: 36999259
[TBL] [Abstract][Full Text] [Related]
17. Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly.
Omuro AM; Taillandier L; Chinot O; Carnin C; Barrie M; Hoang-Xuan K
J Neurooncol; 2007 Nov; 85(2):207-11. PubMed ID: 17896079
[TBL] [Abstract][Full Text] [Related]
18. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
[TBL] [Abstract][Full Text] [Related]
19. Clinical response following adjuvant Temozolomide in a patient with primary cerebral lymphoma.
Strik HM; Spreer A; Nagel H; Jacob S; Jung W; Kitze B; Bähr M
Anticancer Res; 2004; 24(6):4121-5. PubMed ID: 15736462
[TBL] [Abstract][Full Text] [Related]
20. Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma Group.
Pulczynski EJ; Kuittinen O; Erlanson M; Hagberg H; Fosså A; Eriksson M; Nordstrøm M; Østenstad B; Fluge Ø; Leppä S; Fiirgaard B; Bersvendsen H; Fagerli UM
Haematologica; 2015 Apr; 100(4):534-40. PubMed ID: 25480497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
